Search research articles
Contact Us
Filters
Showing results (21-30 of 61) with videos related to
Page
of 7
Sort By:
Nature Reviews. Cancer
|
July 25, 2015
Evolving synergistic combinations of targeted immunotherapies to combat cancer
Ignacio Melero, David M Berman, M Angela Aznar, et al.
The Oncologist
|
April 10, 2023
Efficacy of T-Cell Receptor-Based Adoptive Cell Therapy in Cutaneous Melanoma: A Meta-Analysis
Ramon Yarza, Mateo Bover, Mercedes Herrera-Juarez, et al.
Open Forum Infectious Diseases
|
April 17, 2023
Cytomegalovirus Infections in Patients Treated With Immune Checkpoint Inhibitors for Solid Malignancies
Amalia Anastasopoulou, Michael Samarkos, Panagiotis Diamantopoulos, et al.
Journal for Immunotherapy of Cancer
|
June 14, 2020
Rechallenge patients with immune checkpoint inhibitors following severe immune-related adverse events: review of the literature and suggested prophylactic strategy
John Haanen, Marc Ernstoff, Yinghong Wang, et al.
Cancer Cell
|
March 15, 2022
With one eye on the future
Carlos Caldas, Maria Rescigno, Samra Turajlic, et al.
Acta Oncologica (Stockholm, Sweden)
|
December 23, 2010
A phase I study of recombinant human interleukin-21 (rIL-21) in combination with sunitinib in patients with metastatic renal cell carcinoma (RCC)
Viktor Grünwald, Ingrid M E Desar, John Haanen, et al.
World Journal of Urology
|
January 16, 2009
Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery
Axel Bex, Astrid A M van der Veldt, Christian Blank, et al.
Gynecologic and Obstetric Investigation
|
November 14, 2024
Assisted Reproductive Technology, Pregnancy, and Recurrent Disease in Melanoma Patients: A 30-Year Single Institution Experience
Sander Kelderman, Jorine de Haan, Dachmar Rhijnsburger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2004
On the role of melanoma-specific CD8+ T-cell immunity in disease progression of advanced-stage melanoma patients
Monique van Oijen, Adriaan Bins, Sjoerd Elias, et al.
Journal of Translational Medicine
|
January 28, 2015
NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy
Michel M van den Heuvel, Marcel Verheij, Rogier Boshuizen, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 61) with videos related to
Sort By:
Page
of 7
Nature Reviews. Cancer
|
July 25, 2015
Evolving synergistic combinations of targeted immunotherapies to combat cancer
Ignacio Melero, David M Berman, M Angela Aznar, et al.
The Oncologist
|
April 10, 2023
Efficacy of T-Cell Receptor-Based Adoptive Cell Therapy in Cutaneous Melanoma: A Meta-Analysis
Ramon Yarza, Mateo Bover, Mercedes Herrera-Juarez, et al.
Open Forum Infectious Diseases
|
April 17, 2023
Cytomegalovirus Infections in Patients Treated With Immune Checkpoint Inhibitors for Solid Malignancies
Amalia Anastasopoulou, Michael Samarkos, Panagiotis Diamantopoulos, et al.
Journal for Immunotherapy of Cancer
|
June 14, 2020
Rechallenge patients with immune checkpoint inhibitors following severe immune-related adverse events: review of the literature and suggested prophylactic strategy
John Haanen, Marc Ernstoff, Yinghong Wang, et al.
Cancer Cell
|
March 15, 2022
With one eye on the future
Carlos Caldas, Maria Rescigno, Samra Turajlic, et al.
Acta Oncologica (Stockholm, Sweden)
|
December 23, 2010
A phase I study of recombinant human interleukin-21 (rIL-21) in combination with sunitinib in patients with metastatic renal cell carcinoma (RCC)
Viktor Grünwald, Ingrid M E Desar, John Haanen, et al.
World Journal of Urology
|
January 16, 2009
Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery
Axel Bex, Astrid A M van der Veldt, Christian Blank, et al.
Gynecologic and Obstetric Investigation
|
November 14, 2024
Assisted Reproductive Technology, Pregnancy, and Recurrent Disease in Melanoma Patients: A 30-Year Single Institution Experience
Sander Kelderman, Jorine de Haan, Dachmar Rhijnsburger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2004
On the role of melanoma-specific CD8+ T-cell immunity in disease progression of advanced-stage melanoma patients
Monique van Oijen, Adriaan Bins, Sjoerd Elias, et al.
Journal of Translational Medicine
|
January 28, 2015
NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy
Michel M van den Heuvel, Marcel Verheij, Rogier Boshuizen, et al.
Page
of 7